Worth reading
41Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
3648539
SharesWording
Conditional
How definitive the wording is.This transaction
Share TransfersCounterpartyBausch + Lomb Corporation
Disclosing companyHOYA CORPORATION
The voting-rights ratio is the share of the votes exercisable at a shareholders’ meeting that will be held after this transaction.
TimelineThe spacing between the points is proportional to the actual number of days.White points represent dates designated as scheduled dates in the document.
Target company
Manufacture and sale of vitreous surgery instruments
Location 557 McCormick Street, San Leandro, CA 94577, USAShare capital USD 146 millionDate of incorporation 1981
Net SalesUSD 34 million (fiscal year ending March 2026)
Net income for the current fiscal yearProfit attributable to owners of the parent: USD 5 million (fiscal year ending March 2026)
Net assetsTotal equity: USD 113 million (fiscal year ending March 2026)
Consideration and expenses
Acquisition priceUndisclosed due to confidentiality obligations under the definitive agreement relating to the share transfer
Impact on Business Performance
The impact of the change in the subsidiary on the Company's consolidated results for the current fiscal year will be immaterial.
| Item | Details |
|---|---|
| Transaction name | Share Transfers |
| Counterparty name | Bausch + Lomb Corporation |
| Name of the Subject Company | Medical Instrument Development Laboratories, Inc. (MID Labs) |
| Business Description of the Subject Company | Manufacture and sale of vitreous surgery instruments |
| Location of the Subject Company | 557 McCormick Street, San Leandro, CA 94577, USA |
| Capital Stock of the Subject Company | USD 146 million |
| Date of Establishment of the Subject Company | 1981 |
| Net Sales of the Subject Company | USD 34 million (fiscal year ending March 2026) |
| Net Income of the Subject Company | Profit attributable to owners of the parent: USD 5 million (fiscal year ending March 2026) |
| Net Assets of the Subject Company | Total equity: USD 113 million (fiscal year ending March 2026) |
| Acquisition price | Undisclosed due to confidentiality obligations under the definitive agreement relating to the share transfer |
| Number of shares acquired | 3,648,539 shares; number of voting rights: Not disclosed |
| Voting rights ownership percentage | Before 100％ → after 0％ |
| Impact on Business Performance | The impact of the change in the subsidiary on the Company's consolidated results for the current fiscal year will be immaterial. |
| Contract Date | 9 October 2026 |
| Execution Date / Effective Date | 2 November 2026 (予定) |
Items this document does not state (16)
Operating Profit of the Subject CompanyExpenses other than the acquisition priceType of ConsiderationMerger ratio/share exchange ratioTender offer priceMinimum number of shares to be purchasedTender offer periodFunding arrangementsGoodwill amountAmount of extraordinary income (loss)Date of board resolutionValuation methodologyIndependent valuation institutionSpecial CommitteeConditions Precedent to ExecutionManagement structure after acquisition
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Because it comprehensively considered a review of its business portfolio in light of changes in the external and business environments, the optimal allocation of management resources, and its future growth strategy.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.